Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Alglucerase (Ceredase).

× No keyword cloud information.

11 in total

Review 1. [Gaucher's disease; current developments in the treatment of lysosomal metabolic disease].

Authors: C E Hollak; J M Aerts; R Goudsmit
Journal: Ned Tijdschr Geneeskd Date: 1991-11-16

2. Individualised low-dose alglucerase therapy for type 1 Gaucher's disease.

Authors: C E Hollak; J M Aerts; R Goudsmit; S S Phoa; M Ek; S van Weely; A E von dem Borne; M H van Oers
Journal: Lancet Date: 1995-06-10 Impact factor: 79.321

3. Home treatment with intravenous enzyme replacement therapy for Gaucher disease: an international collaborative study of 33 patients.

Authors: A Zimran; C E Hollak; A Abrahamov; M H van Oers; M Kelly; E Beutler
Journal: Blood Date: 1993-08-15 Impact factor: 22.113

4. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.

Authors: N W Barton; R O Brady; J M Dambrosia; A M Di Bisceglie; S H Doppelt; S C Hill; H J Mankin; G J Murray; R I Parker; C E Argoff
Journal: N Engl J Med Date: 1991-05-23 Impact factor: 91.245

5. Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment.

Authors: A Zimran; D Elstein; R Kannai; S Zevin; I Hadas-Halpern; E Levy-Lahad; Y Cohen; M Horowitz; A Abrahamov
Journal: Am J Med Date: 1994-07 Impact factor: 4.965

6. A less costly regimen of alglucerase to treat Gaucher's disease.

Authors: M L Figueroa; B E Rosenbloom; A C Kay; P Garver; D W Thurston; J A Koziol; T Gelbart; E Beutler
Journal: N Engl J Med Date: 1992-12-03 Impact factor: 91.245

7. Low-dose high-frequency enzyme replacement therapy for very young children with severe Gaucher disease.

Authors: A Zimran; I Hadas-Halpern; S Zevin; E Levy-Lahad; A Abrahamov
Journal: Br J Haematol Date: 1993-12 Impact factor: 6.998

8. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.

Authors: N W Barton; F S Furbish; G J Murray; M Garfield; R O Brady
Journal: Proc Natl Acad Sci U S A Date: 1990-03 Impact factor: 11.205

9. Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources.

Authors: G A Grabowski; N W Barton; G Pastores; J M Dambrosia; T K Banerjee; M A McKee; C Parker; R Schiffmann; S C Hill; R O Brady
Journal: Ann Intern Med Date: 1995-01-01 Impact factor: 25.391

10. Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts.

Authors: S Van Weely; M B Van Leeuwen; I D Jansen; M A De Bruijn; E M Brouwer-Kelder; A W Schram; M C Sa Miranda; J A Barranger; E M Petersen; J Goldblatt
Journal: Biochim Biophys Acta Date: 1991-06-05